These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
85 related articles for article (PubMed ID: 9893036)
41. Administration of anti-interleukin-6 monoclonal antibody prolongs cardiac allograft survival. Lei J; He F; Wu M; Zheng X; Chen X; Chen Z Transpl Int; 2010 Dec; 23(12):1271-81. PubMed ID: 20646257 [TBL] [Abstract][Full Text] [Related]
42. Induction of operational tolerance and generation of regulatory cells after intratracheal delivery of alloantigen combined with nondepleting anti-CD4 monoclonal antibody. Aramaki O; Shirasugi N; Akiyama Y; Takayama T; Shimazu M; Kitajima M; Ikeda Y; Niimi M Transplantation; 2003 Nov; 76(9):1305-14. PubMed ID: 14627908 [TBL] [Abstract][Full Text] [Related]
43. Injection of donor-derived OX62+ splenic dendritic cells with anti-CD4 monoclonal antibody generates CD4+CD25+FOXP3+ regulatory T cells that prolong allograft skin survival indefinitely and abrogate production of donor-specific antibodies in a rat model. Alawieh M; Rifle G; Bouchot O; Malapert G; Mousson C; Martin L Transplant Proc; 2009 Oct; 41(8):3363-6. PubMed ID: 19857750 [TBL] [Abstract][Full Text] [Related]
44. Prolonged survival of mouse skin allografts after transplantation of fetal liver cells transduced with hIL-10 gene. Sembeil R; Sanhadji K; Vivier G; Chargui J; Touraine JL Transpl Immunol; 2004; 13(1):1-8. PubMed ID: 15203122 [TBL] [Abstract][Full Text] [Related]
45. Infusion of donor hepatic non-parenchymal cells prolongs survival of skin allografts in mice: role of microchimerism and IL-4. Ding XM; Xue WJ; Ji ZZ; Tian PX Hepatobiliary Pancreat Dis Int; 2007 Feb; 6(1):34-7. PubMed ID: 17287163 [TBL] [Abstract][Full Text] [Related]
46. T-cell depletion eliminates the development of cardiac allograft vasculopathy in mice rendered tolerant by the induction of mixed chimerism. Uehara S; Chase CM; Colvin RB; Madsen JC; Russell PS Transplant Proc; 2006 Dec; 38(10):3169-71. PubMed ID: 17175214 [TBL] [Abstract][Full Text] [Related]
47. Heart transplants in interferon-gamma, interleukin 4, and interleukin 10 knockout mice. Recipient environment alters graft rejection. Räisänen-Sokolowski A; Mottram PL; Glysing-Jensen T; Satoskar A; Russell ME J Clin Invest; 1997 Nov; 100(10):2449-56. PubMed ID: 9366559 [TBL] [Abstract][Full Text] [Related]
48. Prolongation of survival of fully allogeneic cardiac grafts and generation of regulatory cells by a histamine receptor 2 antagonist. Inoue F; Zhang Q; Akiyoshi T; Aramaki O; Iwami D; Matsumoto K; Kitagawa Y; Shirasugi N; Niimi M Transplantation; 2007 Nov; 84(10):1288-97. PubMed ID: 18049114 [TBL] [Abstract][Full Text] [Related]
49. Prolonged heart allograft survival resulted from donor-specific T-cell sequestering and removal by selective splenectomy in mice. Zhu XH; Chen S; Chen ZK Transplant Proc; 2004 Oct; 36(8):2448-9. PubMed ID: 15561276 [TBL] [Abstract][Full Text] [Related]
50. Prolonged survival of mouse skin allografts in recipients treated with donor splenocytes and antibody to CD40 ligand. Markees TG; Phillips NE; Noelle RJ; Shultz LD; Mordes JP; Greiner DL; Rossini AA Transplantation; 1997 Jul; 64(2):329-35. PubMed ID: 9256196 [TBL] [Abstract][Full Text] [Related]
51. IL-10 and IL-4 in skin allograft survival induced by T-cell depletion plus deoxyspergualin. Asiedu C; Andrades P; Ray PD; George JF; Thomas JM Cell Transplant; 2008; 17(6):713-20. PubMed ID: 18819259 [TBL] [Abstract][Full Text] [Related]
52. Interleukin (IL) 4, the cytokine that isn't there: reactivity of IL-4 antibodies with cells in IL-4 -/- mice. Mottram PL; Purcell LJ; Han WR; Maguire J; Stein-Oakley AN Transplantation; 1997 Mar; 63(6):911-4. PubMed ID: 9089237 [TBL] [Abstract][Full Text] [Related]
53. Fox smell abrogates the effect of herbal odor to prolong mouse cardiac allograft survival. Jin X; Uchiyama M; Zhang Q; Niimi M J Cardiothorac Surg; 2014 May; 9():82. PubMed ID: 24886081 [TBL] [Abstract][Full Text] [Related]
54. Induction of hyporesponsiveness to fully allogeneic cardiac grafts by intratracheal delivery of alloantigen. Shirasugi N; Ikeda Y; Akiyama Y; Matsumoto K; Hamano K; Esato K; Bashuda H; Yagita H; Okumura K; Takami H; Kodaira S; Niimi M Transplantation; 2001 Feb; 71(4):561-4. PubMed ID: 11258436 [TBL] [Abstract][Full Text] [Related]
55. Allograft tolerance induced by cyclophosphamide without prior inoculation of donor cells--immune suppression and redirection. Gao ZH; Lazarovits AI; Wang J; Xing J; Garcia B; Kellersmann R; Kelvin D; Zhong R Transpl Immunol; 2000 Mar; 8(1):65-73. PubMed ID: 10834612 [TBL] [Abstract][Full Text] [Related]
56. Targeting of antihapten antibodies to activated T cells via an IL-2-hapten conjugate prolongs cardiac graft survival. Lussow AR; Fanget L; Gao L; Block M; Buelow R; Pouletty P Transplantation; 1996 Dec; 62(12):1703-8. PubMed ID: 8990347 [TBL] [Abstract][Full Text] [Related]
57. Intragraft overexpression of interleukin-4 is neither sufficient nor essential for tolerance induction to cardiac allografts in a high-responder strain combination. Ritter T; Risch K; Schroder G; Kolls J; Siegling A; Graser E; Reinke P; Brock J; Lehmann M; Volk HD Transplantation; 1999 Nov; 68(9):1427-31. PubMed ID: 10573088 [TBL] [Abstract][Full Text] [Related]
58. Induction of oral tolerance and the effect of interleukin-4 on murine skin allograft rejection. Dettino AL; Duarte AJ; Sato MN Braz J Med Biol Res; 2004 Mar; 37(3):435-40. PubMed ID: 15060714 [TBL] [Abstract][Full Text] [Related]
59. Role of graft interleukin-10 expression in the tolerogenicity of neonatal skin allografts. De Fazio SR; Gozzo JJ Transplantation; 2000 Nov; 70(9):1371-7. PubMed ID: 11087155 [TBL] [Abstract][Full Text] [Related]
60. Effects of Each Domain in Recombinant Human Soluble Thrombomodulin on Prolongation of Murine Cardiac Allograft Survival. Yamamoto Y; Ikeda T; Uchiyama M; Iguchi K; Imazuru T; Shimokawa T Transplant Proc; 2022 Mar; 54(2):487-491. PubMed ID: 35086675 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]